MENU

Moderna posts surprise quarterly profit despite waning demand for Covid vaccines

Moderna maintained its full-year guidance of around $5 billion in revenue from its Covid vaccine, its only marketable product.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
TOP
Email a Story